Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edoxaban for atrial high rate episodes without overt atrial fibrillation
NL-OMON52989Phase 3Recruiting
- Sponsor
- Kompetenznetz Vorhofflimmern
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of edoxaban in atrial high rate episodes (AHRE) and Atrial fibrillation (AFib) (2 arms), sponsored by Kompetenznetz Vorhofflimmern. Started Jul 2017; status: recruiting.
02
Drugs
edoxaban
03
Conditions
atrial high rate episodes (AHRE)Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NL-OMON52989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON52989.